These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 2433864)

  • 1. Trichochromuria in melanosis of melanoma.
    Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
    Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse melanosis and trichochromuria in malignant melanoma.
    Agrup G; Agrup P; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1979; 59(5):456-7. PubMed ID: 93371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some indolic compounds as markers of the melanocyte activity.
    Hansson C
    Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheomelanin-related benzothiazole isomers in the urine of patients with diffuse melanosis of melanoma.
    Nezirević Dernroth D; Arstrand K; Greco G; Panzella L; Napolitano A; Kågedal B
    Clin Chim Acta; 2010 Sep; 411(17-18):1195-203. PubMed ID: 20420819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
    Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of melanocytic metabolites in fertile women.
    Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
    Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichochromes in the urine of melanoma patients.
    Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
    J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
    Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
    Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors.
    Böhm M; Schiller M; Nashan D; Stadler R; Luger TA; Metze D
    J Am Acad Dermatol; 2001 May; 44(5):747-54. PubMed ID: 11312419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffuse melanosis in malignant melanoma].
    Bork K; Korting GW; Rumpelt HJ
    Hautarzt; 1977 Sep; 28(9):463-8. PubMed ID: 914515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of dopa in human albinism.
    Carstam R; Hansson C; Krook G; Rorsman H; Rosengren E; Wirestrand LE
    Acta Derm Venereol; 1985; 65(5):435-7. PubMed ID: 2416170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
    Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
    Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse melanosis in metastatic malignant melanoma.
    Steiner A; Rappersberger K; Groh V; Pehamberger H
    J Am Acad Dermatol; 1991 Apr; 24(4):625-8. PubMed ID: 2033142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffuse melanosis and melanuria in malignant melanoma].
    Woscoff A; Calb IL; Martínez Pizarro R
    Med Cutan Ibero Lat Am; 1984; 12(6):501-8. PubMed ID: 6397672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.